Bi-antigenic immunoassay models based on the recombinant PvpA proteins for Mycoplasma gallisepticum diagnosis in chickens

YAS, Ozlem BUYUKTANIR/0000-0002-7641-7350 WOS: 000284666500009 PubMed: 21088174 The present study aimed to produce the relatively conserved central fragment of the Mycoplasma gallisepticum PvpA cytadhesin as recombinant antigen and to determine its species-specific diagnostic potential in comparison with the full-length recombinant rPvpA336 protein For this purpose a recombinant protein (rPvpA134) consisting of 134 amino acids with apparent molecular mass of 27 kD was produced and highly purified The rPvpA134 protein was composed of the amino acid residues at positions 133-265 with respect to the wild-type PvpA Two bi antigenic diagnostic models based on Western blot and enzymatic rapid immunofiltration assay (ERIFA) were developed to compare simultaneously the diagnostic potential of the recombinant antigens rPvpA134 and rPvpA336 Although 40% of the confirmed rPvpA336-positive chicken sera were detected as reactive with rPvpA134, this protein would be a useful secondary diagnostic antigen with which to confirm species-specific antibody response for monitoring M gallisepticum infections It can be concluded from the present study that 2 bi-antigenic models were successfully adapted to the specific diagnosis of chicken M gallisepticum Furthermore, by virtue of its simplicity and rapidity, the ERIFA model has multi-antigenic application potential making it an alternative field test that is widely applicable in the veterinary diagnostic field Scientific and Technical Research Council of Turkey (Tubitak, Turkey)Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [104T271] This study was supported by grant 104T271 from the Scientific and Technical Research Council of Turkey (Tubitak, Turkey) The authors thank Dr C Yakicier (Bilkent University, Department of Molecular Biology and Genetics, Faculty of Science, Ankara, Turkey) for DNA sequence analysis of the pvpA134 gene fragment